Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jeremy Rawlings"'
Autor:
Pai-Chi Tsai, Shameena Bake, Sridevi Balaraman, Jeremy Rawlings, Rhonda R. Holgate, Dustin Dubois, Rajesh C. Miranda
Publikováno v:
Biology Open, Vol 3, Iss 8, Pp 741-758 (2014)
Ethanol exposure during pregnancy is an established cause of birth defects, including neurodevelopmental defects. Most adult neurons are produced during the second trimester-equivalent period. The fetal neural stem cells (NSCs) that generate these ne
Externí odkaz:
https://doaj.org/article/f624f88171bb48e2ab30b3b82c9268aa
Autor:
Ali, Seifi, Jeremy, Rawlings
Publikováno v:
Journal of the Neurological Sciences. 436:120224
Introduction of the International Classification of Diseases, Tenth Revision (ICD-10) in 2015 was aimed for a more detailed classification of mortality statistics of diseases, such as classifying the anatomical locations for intracerebral hemorrhage
Autor:
Joseph D Tingling, Shameena Bake, Rhonda Holgate, Jeremy Rawlings, Phillips P Nagsuk, Jayashree Chandrasekharan, Sarah L Schneider, Rajesh C Miranda
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e69560 (2013)
BackgroundEthanol is a potent teratogen. Its adverse neural effects are partly mediated by disrupting fetal neurogenesis. The teratogenic process is poorly understood, and vulnerable neurogenic stages have not been identified. Identifying these is a
Externí odkaz:
https://doaj.org/article/ce9e6941fcb04f51852296975e7b7862
Autor:
Jeremy Rawlings, Jason W. Kempenich, Ramy A. Hassan, Daniel L. Dent, Ross E. Willis, Mohammed J. Al Fayyadh, Ronald M. Stewart
Publikováno v:
The American Surgeon. 84:398-402
It has been suggested that in environments where there is greater fear of litigation, resident autonomy and education is compromised. Our aim was to examine failure rates on American Board of Surgery (ABS) examinations in comparison with medical malp
Autor:
Adolfo Enrique Diaz Duque, Sushanth Kakarla, Tyler William Snedden, Prathibha Surapaneni, Jeremy Rawlings, David Gregorio, Snegha Ananth, Joel E. Michalek, Qianqian Liu, Michelle Janania Martinez, Juan Garza
Publikováno v:
Journal of Clinical Oncology. 38:e20083-e20083
e20083 Background: Non-Hodgkin Lymphoma (NHL) continues to be in the top 10 of all cancer related deaths. Discrepancies exist among world regions in lymphoma subtype incidence, with a percentage of DLBCL being higher in Latin America versus Nordic co
Autor:
Jeremy Rawlings, Adolfo Enrique Diaz Duque, Snegha Ananth, Dave Gregorio, Tyler William Snedden, Michelle Janania Martinez, Juan Garza, Sushanth Kakarla, Prathibha Surapaneni, Qianqian Liu, Joel E. Michalek
Publikováno v:
Journal of Clinical Oncology. 38:e20047-e20047
e20047 Background: Follicular Lymphoma (FL) is the most common type of indolent non-Hodgkin lymphoma. It is most commonly diagnosed in non-Hispanics (NH) and is well characterized in this population. Hispanics (HI) on the other hand have been histori
Publikováno v:
Sustainable Cities and Society. 10:245-250
Collectively small and medium sized enterprises (SMEs) are significant energy users although many are unregulated by existing policies due to their low carbon emissions. Carbon reduction is often not a priority but smart grids may create a new opport
Autor:
David Gregorio, Joel E. Michalek, Jeremy Rawlings, Prathibha Surapaneni, Snegha Ananth, Tyler William Snedden, Michelle Janania Martinez, Juan Garza, Qianqian Liu, Sushanth Kakarla, Adolfo E Diaz
Publikováno v:
Blood. 134:2141-2141
Introduction: Historically, a lack of health insurance has been reported to correlate with decreased access to medical care, a delay in cancer treatment and poorer outcomes overall. Furthermore, access to preventive services for cancer screening also
Autor:
Joel E. Michalek, Snegha Ananth, Sushanth Kakarla, Jeremy Rawlings, Qianqian Liu, David Gregorio, Adolfo E Diaz, Michelle Janania Martinez, Juan Garza, Tyler William Snedden, Prathibha Surapaneni
Publikováno v:
Blood. 134:4056-4056
BACKGROUND It is estimated that 8110 persons will be diagnosed with Hodgkin Lymphoma (HL) in the US during 2019, but the advent of new treatment options has increased the cure rate to at least 80%. It has been reported that the rates of HL are lower
Autor:
Joel E. Michalek, Adolfo E Diaz, Michelle Janania Martinez, Prathibha Surapaneni, Juan Garza, Jeremy Rawlings, David Gregorio, Sushanth Kakarla, Qianqian Liu, Snegha Ananth, Tyler William Snedden
Publikováno v:
Blood. 134:2204-2204
BACKGROUND Evidence suggests that co-morbidities at diagnosis can influence treatment decisions and outcomes in lymphoma patients. Considering the bimodal presentation of Hodgkin Lymphoma (HL) and that the majority of Non-Hodgkin lymphoma (NHL) patie